Literature DB >> 15676029

Apoptosis in chronic viral hepatitis parallels histological activity: an immunohistochemical investigation using anti-activated caspase-3 and M30 cytodeath antibody.

Jo L McPartland1, Muna Ali Guzail, Charles H Kendall, James Howard Pringle.   

Abstract

Apoptosis is implicated as a major pathogenic mechanism in chronic hepatitis B and C. Previous studies of the relationship between apoptotic rates and histological necroinflammatory activity have produced conflicting results. Hepatocyte apoptosis was assessed in liver tissue from 32 cases of chronic viral hepatitis, seven cases of hepatocellular carcinoma (HCC) and six cases of steatohepatitis as non-viral disease controls and eight cases of control liver. Apoptotic rates were measured using H&E morphological assessment and immunohistochemical staining with antibodies to activated caspase-3 and M30. Histological necroinflammatory activity of viral hepatitis cases was scored using the Knodell scoring system, and the cases were divided according to their score into group 1 (mean 2.43 +/- 0.48) and group 2 (mean 7.80 +/- 0.49). Apoptotic indices were significantly higher in group 2 than group 1 using H&E (11.53 +/- 2.70 vs. 0 +/- 0, P=0.015) and activated caspase-3 (22.01 +/- 5.27 vs. 1.79 +/- 1.79, P=0.03) methods but were not significantly higher with M30 (3.80 +/- 1.74 vs. 0 +/- 0, P=0.207). Apoptotic scores using an antibody to activated caspase-3 are significantly higher in cases of chronic viral hepatitis with greater histological necroinflammatory scores, supporting a central role for apoptosis in disease pathogenesis. This method offers an alternative to routine histological assessment for measuring disease activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15676029      PMCID: PMC2517396          DOI: 10.1111/j.0959-9673.2005.00411.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  29 in total

1.  TUNEL apoptotic cell detection in tissue sections: critical evaluation and improvement.

Authors:  F Labat-Moleur; C Guillermet; P Lorimier; C Robert; S Lantuejoul; E Brambilla; A Negoescu
Journal:  J Histochem Cytochem       Date:  1998-03       Impact factor: 2.479

Review 2.  Apoptosis in liver disease.

Authors:  P R Galle
Journal:  J Hepatol       Date:  1997-08       Impact factor: 25.083

Review 3.  Cytotoxic T cells and viral hepatitis.

Authors:  F V Chisari
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

4.  Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis.

Authors:  R U Jänicke; M L Sprengart; M R Wati; A G Porter
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

5.  Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes.

Authors:  M Woo; R Hakem; M S Soengas; G S Duncan; A Shahinian; D Kägi; A Hakem; M McCurrach; W Khoo; S A Kaufman; G Senaldi; T Howard; S W Lowe; T W Mak
Journal:  Genes Dev       Date:  1998-03-15       Impact factor: 11.361

Review 6.  Caspases: the executioners of apoptosis.

Authors:  G M Cohen
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

Review 7.  Diagnosis and interpretation of steatosis and steatohepatitis.

Authors:  A D Burt; A Mutton; C P Day
Journal:  Semin Diagn Pathol       Date:  1998-11       Impact factor: 3.464

8.  Fas antigen expression in liver tissues of patients with chronic hepatitis B.

Authors:  K Mochizuki; N Hayashi; N Hiramatsu; K Katayama; Y Kawanishi; A Kasahara; H Fusamoto; T Kamada
Journal:  J Hepatol       Date:  1996-01       Impact factor: 25.083

9.  In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note.

Authors:  B Grasl-Kraupp; B Ruttkay-Nedecky; H Koudelka; K Bukowska; W Bursch; R Schulte-Hermann
Journal:  Hepatology       Date:  1995-05       Impact factor: 17.425

Review 10.  Active cell death: role in hepatocarcinogenesis and subtypes.

Authors:  W Bursch; B Grasl-Kraupp; A Ellinger; L Török; H Kienzl; L Müllauer; R Schulte-Hermann
Journal:  Biochem Cell Biol       Date:  1994 Nov-Dec       Impact factor: 3.626

View more
  4 in total

1.  Effects of JC virus infection on anti-apoptotic protein survivin in progressive multifocal leukoencephalopathy.

Authors:  Sergio Piña-Oviedo; Katarzyna Urbanska; Sujatha Radhakrishnan; Thersa Sweet; Krzysztof Reiss; Kamel Khalili; Luis Del Valle
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

2.  The multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis.

Authors:  Mahmoud Elshal; Nashwa Abu-Elsaad; Amr El-Karef; Tarek Mostafa Ibrahim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-14       Impact factor: 3.000

3.  Caspase-cleaved cytokeratin 18 and 20 S proteasome in liver degeneration.

Authors:  Hubert Hetz; Konrad Hoetzenecker; Stefan Hacker; Peter Faybik; Andreas Pollreisz; Bernhard Moser; Georg Roth; Wolfram Hoetzenecker; Michael Lichtenauer; Markus Klinger; Claus Georg Krenn; Hendrik Jan Ankersmit
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

4.  Total and caspase-cleaved cytokeratin 18 in chronic cholecystitis: a prospective study.

Authors:  Constantinos Simopoulos; Alexandra K Tsaroucha; Byron Asimakopoulos; Alexandra Giatromanolaki; Paschalis Gavriilidis; Alexandros Polychronidis; Anastasios Karayiannakis
Journal:  BMC Gastroenterol       Date:  2008-05-06       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.